Literature DB >> 29862953

Factors associated with the drug-resistant tuberculosis incidence rate in Brazil.

M G Jacobs1, D M Pelissari2, V L Pinto3.   

Abstract

SETTING: The selection and transmission of drug-resistant strains of tuberculosis (TB) hamper disease control.
OBJECTIVE: To identify health conditions, demographic and socio-economic factors, as well as individual factors associated with the incidence of drug-resistant TB (DR-TB), in Brazil at the municipal level.
DESIGN: This was an ecological study covering Brazilian municipalities that had reported DR-TB cases in 2014. Associations were evaluated in a multilevel analysis using negative binomial regression.
RESULTS: In the multilevel model, males (incidence rate ratio [IRR] 2.6, 95% confidence interval [CI] 2.3-2.93) and Black persons (IRR 1.82, 95%CI 1.61-2.05) had a higher risk of DR-TB. Compared with those aged 60 years, persons aged 15-59 years (IRR 1.72, 95%CI 1.40-2.11) also had a higher risk. The following contextual factors were associated with the incidence rate (IR) of DR-TB: proportion of previously treated patients (IRR 1.27, 95%CI 1.1-1.5), acquired immune-deficiency syndrome IR (IRR 1.13, 95%CI 1.02-1.25), Municipal Human Development Index (IRR 0.72, 95%CI 0.64-0.81) and the Gini coefficient (IRR 0.86, 95%CI 0.78-0.95).
CONCLUSION: We have identified individual and contextual factors associated with the incidence of DR-TB. Our results may help improve integrated public health interventions aimed at controlling DR-TB in Brazil.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29862953     DOI: 10.5588/ijtld.17.0667

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  1 in total

1.  Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting.

Authors:  Kevin Montes; Himachandana Atluri; Hibeb Silvestre Tuch; Lucrecia Ramirez; Juan Paiz; Ana Hesse Lopez; Thomas C Bailey; Andrej Spec; Carlos Mejia-Chew
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.